DEFA14A: Premier, Inc. Goes Private in Patient Square Capital Deal

Premier, Inc. has agreed to be acquired by an affiliate of Patient Square Capital, transitioning to private ownership to enhance financial flexibility and accelerate innovation.

Summary

• Premier, Inc. has entered into an agreement to be acquired by an affiliate of Patient Square Capital, a dedicated healthcare investment firm.
• Upon completion of the transaction, Premier will transition from a publicly traded company to a private entity.
• The move to private ownership is expected to provide Premier with enhanced financial flexibility and additional resources.
• This strategic partnership aims to accelerate the advancement and tech-enablement of Premier's product portfolio, capitalize on emerging opportunities, and drive innovation.
• Premier plans to continue building on its existing portfolio, which includes supply chain services, data and technology offerings, and consulting solutions.
• The company will file a proxy statement (Schedule 14A) with the U.S. Securities and Exchange Commission (SEC) for stockholder consideration of the proposed transaction.

Sentiment

Score: 7

Explanation: The acquisition by Patient Square Capital is presented as a strategic move to enhance financial flexibility, accelerate innovation, and capitalize on opportunities, which are positive for the company's long-term growth prospects. However, it also entails standard transaction risks and the cessation of public trading for current shareholders.

Positives

• Enhanced financial flexibility and access to additional resources through the partnership with Patient Square Capital.
• Opportunity to accelerate portfolio advancement and tech-enablement, fostering innovation.
• Ability to capitalize more effectively on emerging opportunities in the healthcare sector.
• Partnership with a dedicated healthcare investment firm focused on improving health through products, services, and technologies.

Negatives

• The company will cease to be publicly traded, meaning current public shareholders will no longer hold shares in Premier, Inc. after the transaction.
• Potential for adverse effects on the market price of Premier Class A Common Stock due to announcements related to the proposed transaction.
• Risk of disruption from the proposed transaction making it more difficult to maintain business and operational relationships, including retaining and hiring key personnel.
• Incurrence of significant transaction costs associated with the acquisition.
• Risk of litigation and/or regulatory actions related to the proposed transaction.

Risks

• Inability to consummate the proposed transaction within the anticipated time period, or at all, due to reasons such as failure to obtain required regulatory approvals, stockholder approval, or complete contemplated financing arrangements.
• Adverse effects on the market price of Premier Class A Common Stock resulting from announcements related to the proposed transaction.
• Disruption from the proposed transaction making it more difficult to maintain business and operational relationships, including retaining and hiring key personnel and maintaining relationships with customers, vendors, and other business partners.
• The occurrence of any event, change, or other circumstances that could give rise to the termination of the merger agreement.
• Risks related to disruption of Premier's current plans and operations or the diversion of management's attention from ongoing business operations due to the proposed transaction.
• Significant transaction costs associated with the acquisition.
• Risk of litigation and/or regulatory actions related to the proposed transaction or unfavorable results from currently pending or future litigation and proceedings.

Future Outlook

The proposed transaction is expected to provide additional resources and flexibility to accelerate portfolio advancement and tech-enablement, capitalize on emerging opportunities, and drive innovation. Premier anticipates continuing to build on its differentiated portfolio in supply chain services, data and technology offerings, and consulting solutions.

Management Comments

• "We are excited to share that Premier has agreed to be acquired by an affiliate of Patient Square Capital, a dedicated healthcare investment firm focused on partnering with companies and management teams whose products, services and technologies improve health."
• "Following completion of the transaction, Premier will be a private company."
• "Transitioning to private ownership will enhance Premier's financial flexibility and provide additional resources to accelerate the advancement and tech-enablement of our product portfolio, capitalize on emerging opportunities and continue pushing the envelope of innovation."
• "We look forward to partnering with Patient Square Capital as we continue building on our differentiated portfolio in supply chain services, data and technology offerings, and consulting solutions that deliver value to patients."

Industry Context

The acquisition of a healthcare services and technology company by a dedicated healthcare investment firm reflects a broader trend of private equity firms seeking to invest in and optimize companies within the resilient and growing healthcare sector. This often involves leveraging private capital to accelerate technological adoption, expand service offerings, and consolidate market positions, aiming for long-term value creation away from public market pressures.

Stakeholder Impact

• Shareholders: Will receive consideration for their shares as the company transitions to private ownership; urged to vote on the proposed transaction.
• Employees: Risk of disruption from the transaction making it more difficult to retain and hire key personnel.
• Customers, Vendors, and Other Business Partners: Risk of disruption making it more difficult to maintain existing business relationships.
• Management: Attention may be diverted from ongoing business operations due to the demands of the proposed transaction.

Next Steps

• The Company will file relevant materials with the U.S. Securities and Exchange Commission (SEC), including a proxy statement on Schedule 14A.
• The proposed transaction will be submitted to the Company's stockholders for their consideration and approval.
• Stockholders are urged to read all relevant documents filed or to be filed with the SEC, including the Proxy Statement, when they become available.
• The transaction requires obtaining necessary regulatory approvals.
• Completion of contemplated financing arrangements is required for the transaction to close.

Key Dates

Recommendation

The company has announced its agreement to be acquired and taken private. For existing shareholders, the prudent action is to hold shares until the full terms of the acquisition, including the per-share price, are disclosed in the proxy statement. This allows shareholders to capture any premium offered by the acquisition, assuming the deal closes as expected. New investors would need to evaluate the offer price against the current market price for potential arbitrage opportunities, which are not detailed in this preliminary filing.

Keywords

Acquisition, Healthcare, Private Equity, Patient Square Capital, Premier Inc, Merger, Supply Chain, Technology, Consulting, SEC Filing